Gender and gallstone disease

Wiener Medizinische Wochenschrift

Volumn 156, Issue 19-20, 2006, Pages 527-533

  Novacek, Gottfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Estrogen; Gallstones; Gender; Hormone replacement therapy; Oral contraceptives; Pregnancy; Progesterone

Indexed keywords

BILE ACID; CALCIUM CARBONATE; CHOLESTEROL; ESTROGEN; GLYCOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MUCOGLYCOPROTEIN; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SEX HORMONE; UNCLASSIFIED DRUG;

AMERICAN INDIAN; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DENMARK; DOSE RESPONSE; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; EUROPE; FOLLOW UP; GROUPS BY AGE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOGENESIS; POSTMENOPAUSE; PREGNANCY; PREVALENCE; REVIEW; RISK FACTOR; SCANDINAVIA; SEX DIFFERENCE; SOCIETY; SYSTEMIC DISEASE; WEIGHT REDUCTION;

ADULT; AGE FACTORS; BILE; CHOLESTEROL; CONTRACEPTIVES, ORAL; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GALLSTONES; HUMANS; MALE; MIDDLE AGED; PARITY; PREGNANCY; RISK FACTORS; SEX CHARACTERISTICS;

EID: 33751326499     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-006-0346-x     Document Type: Review

References (65)

1. Barbara L, Sama C, Labate AMM, Taroni F, Rusticali AG, Festi D, Sapio C, Roda E, Banterle C, Puci A, Formentini F, Colasanti S, Nardin F (1987) A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology 7: 913-917
2. Glambek I, Kvaale G, Arnesjö B, Søreide O (1987) Prevalence of gallstones in Norwegian population. Scand J Gastroenterol 22: 1089-1094
3. Jørgensen T (1987) Prevalence of gallstones in a Danish population. Am J Epidemiol 126: 912-921
4. Kratzer W, Krön M, Hay B, Pfeiffer MM, Kächele V (1999) Prävalenz der Cholezystolithiasis in Süddeutschland - eine sonographische Untersuchung an 2.498 Personen einer ländlichen Bevölkerung. Z Gastroenterol 37: 1157-1162
5. Volzke H, Baumeister SE, Alte D, Hoffmann W, Schwahn C, Simon P, John U, Lerch MM (2005) Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 71: 97-105
6. Maurer KR, Everhart JE, Ezzati TM, Johannes RS, Knowler WC, Larson DL, Sanders R, Shawker TH, Roth HP (1989) Prevalence of gallstone disease in Hispanic populations in the United States. Gastroenterology 96: 487-492
7. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA (1970) Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 283: 1358-1364
8. Williams CN, Johnston JL, Weldon KL (1977) Prevalence of gallstones and gallbladder disease in Canadian Micmac Indian women. Can Med Assoc J 117: 758-760
9. Kratzer W, Mason RA, Kachele V (1999) Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 27: 1-7
10. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Ikematsu H, Noguchi A, Tani S, Goto M (1988) Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol 128: 598-605
11. Jensen KH, Jørgensen T (1991) Incidence of gallstones in a Danish population. Gastroenterology 100: 790-794
12. Small DM (1976) The etiology and pathogenesis of gallstones. Adv Surg 10: 63-85
13. Kurtin WE, Schwesinger WH, Diehl AK (2000) Age-related changes in the chemical composition of gallstones. Int J Surg Investig 2: 299-307
14. Horton JD, Bilhartz LE (2002) Gallstone disease and its complications. In: Feldman M, Friedman LS, Sleisenger MH (eds.) Sleisenger and Fordtran's gastrointestinal and liver disease, 7th edition. Saunders, Philadelphia, pp 1065-1090
15. Donovan JM, Carey MC (1990) Separation and quantitation of cholesterol "carriers" in bile. Hepatology 12: 94S-104S
16. Lamont JT, Carey MC (1992) Cholesterol gallstone formation. 2. Pathobiology and pathomechanics. Prog Liver Dis 10: 165-191
17. Carey MC, Small DM (1978) The physical chemistry of cholesterol solubility in bile: Relationship to gallstone formation and dissolution in man. J Clin Invest 61: 998-1026
18. Miquel JF, Nunez L, Amigo L, Gonzalez S, Raddatz A, Rigotti A, Nervi F (1998) Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile. Gastroenterology 114: 1016-1023
19. Brown MS, Goldstein JL (1976) Receptor-mediated control of cholesterol metabolism. Science 191: 150-154
20. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ (1979) Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 77: 611-617
21. Sedaghat A, Grundy SM (1980) Cholesterol crystals and the formation of cholesterol gallstones. N Engl J Med 302: 1274-1277
22. Marks JW, Broomfield P, Bonorris GG, Schoenfield LJ (1991) Factors affecting the measurement of cholesterol nucleation in human gallbladder and duodenal bile. Gastroenterology 101: 214-219
23. Lee SP, Lamont JT, Carey MC (1981) The role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones: studies in the prairie dog. J Clin Invest 67: 1712-1723
24. Gallinger S, Taylor RD, Harvey PR, Petrunka CN, Strasberg SM (1985) Effect of mucous glycoprotein on nucleation time in human bile. Gastroenterology 98: 648-658
25. Van Erpecum KJ, Portincasa P, Dohlu MH, Van Berge-Henegouwen GP, Jüngst D (2003) Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients. J Hepatol 39: 7-11
26. Smith BF (1987) Human gallbladder mucin binds biliary lipids and promotes cholesterol crystal nucleation in model bile. J Lipid Res 28: 1088-1097
27. Afdhal NH, Niu N, Nunes DP, Bansil R, Cao XX, Gantz D, Small DM, Offner GD (1995) Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation. Hepatology 22: 856-865
28. Wood JR, Svanvik J (1983) Gall-bladder water and electrolyte transport and its regulation. Gut 24: 579-593
29. Ko CW, Sekijima JH, Lee SP (1999) Biliary sludge. Ann Intern Med 130: 301-311
30. Lee SP, Maher K, Nicholls JF (1988) Origin and fate of biliary sludge. Gastroenterology 94: 170-176
31. Cetta F (1991) The role of bacteria in pigment gallstone disease. Ann Surg 213: 315-326
32. Stewart L, Oesterle AL, Erdan I, Griffiss JM, Way LW (2002) Pathogenesis of pigment gallstones in Western societies: the central role of bacteria. J Gastrointest Surg 6: 891-903
33. Gracie WA, Ransohoff DF (1982) The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 307: 798-800
34. Attili AF, De Santis A, Capri R, Repice AM, Maselli S, and the GREPCO Group (1995) The natural history of gallstones: the GREPCO experience. Hepatology 21: 656-660
35. Halldestam I, Enell EL, Kullman E, Borch K (2004) Development of symptoms and complications in individuals with asymptomatic gallstones. BrJ Surg 91: 734-738
36. Thistle JL, Cleary PA. Lachin JM, Tyor MP, Hersh T (1984) The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Internal Med 101: 171-175
37. Houdart R, Perniceni T, Darne B, Salmeron M, Simon JF (1995) Predicting common bile duct lithiasis: determination and prospective validation of a model predicting low risk. Am J Surg 170: 38-43
38. Ott DJ, Gilliam JH 3rd, Zagoria RJ, Young GP (1992) Interventional endoscopy of the biliary and pancreatic ducts: current indications and methods. Am J Roentgenol 158: 243-250
39. Fulcher AS (2002) MRCP and ERCP in the diagnosis of common bile duct stones. Gastrointest Endosc 56: S178-182
40. Moon JH, Cho YD, Cha SW, Cheon YK, Ahn HC, Kim YS, Kim YS, Lee JS, Lee MS, Lee HK, Shim CS, Kim BS (2005) The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US. Am J Gastroenterol 100: 1051-1057
41. Hochwalk SN, Dobryansky MBA, Rofsky NM, Naik KS, Shamamian P, Coppa G, Marcus SG (1998) Magnetic resonance cholangiopancreatography accurately predicts the presence or absence of choledocholithiasis. J Gastrointest Surg 2: 573-579
42. Sivak MV Jr (2002) EUS for bile duct stones: how does it compare with ERCP? Gastrointest Endosc 56: S175-177
43. Valdivieso V, Covarrubias C, Siegel F. Cruz F (1993) Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology 17: 159-161
44. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P. Marschall HU (2005) Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 41: 1138-1143
45. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC (1992) Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 55: 652-658
46. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E. Barbara L, Capocaccia L, Menotti A, Okolicsanyi L, Ricci G, Lalloni L, Mariotti S, Sama C, Scafato E, and the MICOL Group (1997) Factors associated with gallstone disease in the MICOL experience. Hepatology 26: 809-818
47. Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW (1991) Gallstone formation after rapid weight loss: A propective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86: 1000-1005
48. De Santis A, Attili AF, Corradini GS, Scafato E, Cantagalli A. De Luca C, Pinto G, Lisi D, Capocaccia L (1997) Gallstones and diabetes: a case-control study in a free-living population sample. Hepatology 25: 787-790
49. Lapidus A, Bangstad M, Astrom M, Muhrbeck O (1999) The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease. Am J Gastroenterol 94: 1261-1266
50. Uhler M, Marks JW, Judd HL (2000) Estrogen replacement therapy and gallbladder disease in postmenopausal women. Menopause 7: 162-167
51. Grodstein F, Colditz GA, Stampfer MJ (1994) Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol 83: 5-11
52. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613
53. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix A, Limacher MC, Larson JC (2005) Effect of estrogen therapy on gallbladder disease. JAMA 293: 330-339
54. Uhler ML, Marks JW, Voigt BJ, Judd HL (1998) Comparison of the impact of transdermal versus oral estrogen on biliary markers. J Clin Endocrinol Metab 83: 410-414
55. Scragg RKR, McMichael AJ, Seamark RF (1984) Oral concraceptives, pregnancy, and endogenous oestrogen in gall stone disease - a case control study. BMJ 288: 1795-1799
56. Strom BL, Tamragouri RN, Morse ML, Lazar EL, West SL, Stolley PD, Jones JK (1986) Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther 39: 335-341
57. Thijs C, Leffers P, Knipschild P (1993) Oral contraceptive use and the occurrence of gallstone disease - a case-control study. Prev Med 22: 12-31
58. Thijs C, Knipschild P (1993) Oral contraceptives and the risk of gallbladder disease: a meta-analysis. Am J Public Health 83: 1113-1120
59. Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, Mossa A, Noviello MR, Coviello A, Minutolo MC, Mangini V, Messa C, Cavallini A, De Michele G, Giogio I (1996) Epidemiology of cholelithiasis in southern Italy. Part II: risk factors. Eur J Gastroenterol Hepatol 8: 585-593
60. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B (1989) Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 84: 811-816
61. Maringhini A, Ciambra M, Baccelliere P, Raimondo M, Orlando A, Tinè F, Grasso R, Randazzo MA, Barresi L, Gullo D, Musicò M, Pagliaro (1993) Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med 119: 116-120
62. Ko CW, Beresford SA, Schulte SJ, Matsumoto AM, Lee SP (2005) Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 41: 359-365
63. Wang HH, Afdhal NH, Wang DQH (2004) Estrogen receptor α, but not β, plays a major role in 17β-estradiol-induced murine cholesterol gallstones. Gastroenterology 127: 239-249
64. Kern FJr, Everson GT, DeMark B, McKinley C, Showalter R, Erfling W, Braverman DZ, Szczepanik-vanLeeuwen P, Klein PD (1981) Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest 68: 1229-1242
65. Van Bodegraven AA, Bohmer CJ, Manoliu RA, Paalman E, Van der Klis AH, Roex AJ, Kruishoop AM, Deville WL, Lourens J (1998) Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol 33: 993-997